These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16912204)

  • 1. Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy.
    Bai XF; Liu JQ; Joshi PS; Wang L; Yin L; Labanowska J; Heerema N; Zheng P; Liu Y
    Cancer Res; 2006 Aug; 66(16):8241-9. PubMed ID: 16912204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires.
    Sarma S; Bai XF; Liu JQ; May KF; Zheng P; Liu Y
    Cancer Res; 2003 Sep; 63(18):6051-5. PubMed ID: 14522934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected.
    Ramarathinam L; Sarma S; Maric M; Zhao M; Yang G; Chen L; Liu Y
    J Immunol; 1995 Dec; 155(11):5323-9. PubMed ID: 7594546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S; May KF; Tzou KS; Lin T; Bhatt D; Freud AG; Guimond M; Ferketich AK; Liu Y; Caligiuri MA
    Cancer Res; 2004 Nov; 64(21):8062-7. PubMed ID: 15520217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased tumor surveillance after adoptive T-cell therapy.
    Matter M; Pavelic V; Pinschewer DD; Mumprecht S; Eschli B; Giroglou T; von Laer D; Ochsenbein AF
    Cancer Res; 2007 Aug; 67(15):7467-76. PubMed ID: 17671217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells.
    Wall EM; Milne K; Martin ML; Watson PH; Theiss P; Nelson BH
    Cancer Res; 2007 Jul; 67(13):6442-50. PubMed ID: 17616705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
    Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
    Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy.
    Thanarajasingam U; Sanz L; Diaz R; Qiao J; Sanchez-Perez L; Kottke T; Thompson J; Chester J; Vile RG
    Cancer Res; 2007 Jan; 67(1):300-8. PubMed ID: 17210711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical development of T cell receptor gene therapy.
    Bendle GM; Haanen JB; Schumacher TN
    Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes.
    Bai XF; Liu J; Li O; Zheng P; Liu Y
    J Clin Invest; 2003 May; 111(10):1487-96. PubMed ID: 12750398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.
    Sarma S; Guo Y; Guilloux Y; Lee C; Bai XF; Liu Y
    J Exp Med; 1999 Mar; 189(5):811-20. PubMed ID: 10049945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
    Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
    Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
    Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
    Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive T-cell therapy of cancer.
    Yee C
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):711-33. PubMed ID: 16762731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down-modulation.
    Ney JT; Schmidt T; Kurts C; Zhou Q; Eckert D; Felsher DW; Schorle H; Knolle P; Tüting T; Barchet W; Büttner R; Limmer A; Gütgemann I
    Hepatology; 2009 Feb; 49(2):471-81. PubMed ID: 19105207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells.
    Savai R; Schermuly RT; Pullamsetti SS; Schneider M; Greschus S; Ghofrani HA; Traupe H; Grimminger F; Banat GA
    Cancer Res; 2007 Jun; 67(11):5443-53. PubMed ID: 17545626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of P815 tumor immunity by DNA-based recombinant Semliki Forest virus or replicon DNA expressing the P1A gene.
    Ni B; Lin Z; Zhou L; Wang L; Jia Z; Zhou W; Diciommo DP; Zhao J; Bremner R; Wu Y
    Cancer Detect Prev; 2004; 28(6):418-25. PubMed ID: 15582265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of dual-specific T cells and influenza virus.
    Murphy A; Westwood JA; Brown LE; Teng MW; Moeller M; Xu Y; Smyth MJ; Hwu P; Darcy PK; Kershaw MH
    Cancer Gene Ther; 2007 May; 14(5):499-508. PubMed ID: 17332777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs.
    Zhang Y; Wakita D; Chamoto K; Narita Y; Matsubara N; Kitamura H; Nishimura T
    Int Immunol; 2007 Feb; 19(2):151-61. PubMed ID: 17189593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.